Novo Nordisk (PK) Quote - NONOF

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

131.50

Bid

129.84

Ask

135.36

Volume

1,267

131.50 Day's Range 133.15

75.50 52 Week Range 149.55

Market Cap

609.659B

Previous Close

135.60

Open

133.15

Last Trade

135

131.5

Last Trade Time

Financial Volume

US$ 167,309

VWAP

132.0514

Average Volume (3m)

54,344

Shares Outstanding

4,496,011,436

Dividend Yield

PE Ratio

7.07

Earnings Per Share (EPS)

18.61

Revenue

232.26B

Net Profit

83.68B

Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, ... Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven(R) RT), growth hormone therapy, hormone replacement therapy and other products. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novonordisk.com

Headquarters

Bagsvaerd, Dnk

Founded

1970

Novo Nordisk (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NONOF. The last closing price for Novo Nordisk (PK) was US$135.60. Over the last year, Novo Nordisk (PK) shares have traded in a share price range of US$ 75.50 to US$ 149.55.

Novo Nordisk (PK) currently has 4,496,011,436 shares outstanding. The market capitalization of Novo Nordisk (PK) is US$609.66 billion. Novo Nordisk (PK) has a price to earnings ratio (PE ratio) of 7.07.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-9.2	-6.53873489694	140.7	146	126.37	16410	140.2258374	CS
4	-6.2001	-4.50261110921	137.7001	149.55	126.37	41373	139.98826945	CS
12	2.42	1.87480632166	129.08	149.55	119.648	54344	140.12689681	CS
26	24.5	22.8971962617	107	149.55	102.5	46524	131.65806618	CS
52	52.505	66.46623204	78.995	149.55	75.5	36778	118.38956799	CS
156	87.25	197.175141243	44.25	149.55	43.32	25868	87.09272529	CS
260	107.64125	451.160475716	23.85875	149.55	23.7221	23052	69.09885424	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FTFortune Minerals Limited	$ 0.085 (30.77%)	653.54k
YRBYorbeau Resources Inc	$ 0.045 (28.57%)	126k
BSXBelo Sun Mining Corp	$ 0.055 (22.22%)	22.61k
CTXCrescita Therapeutics Inc	$ 0.59 (19.19%)	222.87k
AVCNAvicanna Inc	$ 0.43 (17.81%)	11.5k
NCFNorthcliff Resources Ltd	$ 0.02 (-20.00%)	34k
AEGAegis Brands Inc	$ 0.36 (-10.00%)	1.06k
BABYElse Nutrition Holdings Inc	$ 0.135 (-10.00%)	420.07k
GRCGold Springs Resource Corp	$ 0.095 (-9.52%)	500
GIVXGivex Corp	$ 0.86 (-9.47%)	177k
RYRoyal Bank of Canada	$ 152.65 (-0.72%)	10.74M
ENBEnbridge Inc	$ 50.20 (0.92%)	8.41M
TRPTC Energy Corporation	$ 56.43 (2.08%)	4.59M
BTEBaytex Energy Corp	$ 5.09 (0.99%)	4.58M
BITFBitfarms Ltd	$ 3.83 (4.08%)	4.23M